← Back to Patent Explorer
US4323358A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for inhibiting mineralization of natural tissue during implantation

Assignee: Medtronic Inc
•
Filing: 1981-04-30
•
Granted: 1982-04-06
•
Expires: 2001-04-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Natural tissues fixed with a tanning solution such as glutaraldehyde and intended for implantation in humans, e.g., porcine heart valve prosthetic devices, are treated with a solution of a water soluble salt of a sulfated higher aliphatic alcohol such as sodium dodecyl sulfate to inhibit mineralization, particularly calcification, of the tissue after implantation.

Inventors

  • 👤 David J. Lentz
  • 👤 Elisabeth M. Pollock

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 17:34
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3683; A61L27/3687; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2412; A61L2400/00; A61L2400/02; Y; Y10; Y10S; Y10S623/00; Y10S623/915; Y10S623/916

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 39 words
A method for inhibiting the mineralization of fixed natural tissue after implantation in a living body comprising contacting fixed natural tissue intended for implantation with an aqueous solution of a water soluble salt of a C 7-18 alkyl sulfate.
Claim 2
Independent Claim 39 words
A method for inhibiting the mineralization of fixed natural tissue after implantation in a living body comprising contacting fixed natural tissue intended for implantation with an aqueous solution of a water soluble salt of a C 7-18 alkyl sulfate.
Claim 3
Dependent Claim 18 words
The method of claim 1 wherein the aqueous solution is buffered to a pH of 4.0 to 9.0.
Claim 4
Dependent Claim 23 words
The method of claim 1 wherein the water soluble salt is selected from the group consisting of sodium, potassium, ammonium and amine salts.
Claim 5
Dependent Claim 16 words
The method of claim 1 wherein the C 7-18 alkyl is a straight chain aliphatic group.
Claim 6
Dependent Claim 14 words
The method of claim 1 wherein C 7-18 alkyl is a branched aliphatic group.
Claim 7
Dependent Claim 24 words
The method of claim 1 wherein C 7-18 alkyl sulfate is selected from the group consisting of lauryl, myristyl, cetyl, steryl and oleyl sulfate.
Claim 8
Dependent Claim 33 words
The method of claim 1 wherein said natural tissue is contacted with said salt of C 7-18 alkyl sulfate for a time sufficient to effectively inhibit future calcification of said tissue after implantation.
Claim 9
Dependent Claim 29 words
The method of claim 7 wherein said tissue is contacted with said salt of C 7-18 alkyl sulfate for a period of at least 4 hours at room temperature.
Claim 10
Dependent Claim 27 words
The method of claim 1 wherein the concentration of said salt of C 7-18 alkyl sulfate in said solution is from about 0.1 to 5% by weight.
Claim 11
Dependent Claim 17 words
The method of claim 9 wherein the solution is buffered to a pH of 7.0 to 7.5.
Claim 12
Independent Claim 45 words
A method for inhibiting the calcification of fixed natural tissue after implantation in a living body which comprises contacting fixed tissue intended for implantation with a solution comprising sodium dodecyl sulfate for a time sufficient to effectively inhibit future calcification of said tissue after implantation.
Claim 13
Independent Claim 45 words
A method for inhibiting the calcification of fixed natural tissue after implantation in a living body which comprises contacting fixed tissue intended for implantation with a solution comprising sodium dodecyl sulfate for a time sufficient to effectively inhibit future calcification of said tissue after implantation.
Claim 14
Dependent Claim 19 words
The method of claim 11 wherein said solution comprises from about 0.1 to 5% by weight sodium dodecyl sulfate.
Claim 15
Dependent Claim 22 words
The method of claim 11 wherein said tissue is contacted with said solution for a time of at least about 4 hours.
Claim 16
Dependent Claim 19 words
The method of claim 11 wherein said solution is buffered to a pH of from about 7.0 to 7.5.
Claim 17
Dependent Claim 22 words
The method of claim 11 wherein the solution is buffered to a pH of about 7.4 with about 0.005 M N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid.
Claim 18
Dependent Claim 15 words
The method of claim 15 wherein the concentration of sodium dodecyl sulfate is about 1%.
Claim 19
Dependent Claim 27 words
The method of claim 16 wherein the tissue is contacted with said solution of sodium dodecyl sulfate for a period of about 24 hours at ambient temperature.
Claim 20
Dependent Claim 15 words
The method of claim 11 wherein the fixed tissue is a glutaraldehyde-fixed porcine heart valve.
Claim 21
Dependent Claim 12 words
The method of claim 11 wherein said living body is a human.

References Cited (Backward Citations)

SU559701A1 Cited
US3966401A Cited
US4050893A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-04-05 1985-10-05 1986-04-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-04-05 1989-10-05 1990-04-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-04-05 1993-10-05 1994-04-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag